SciClone Reports 2016 Financial Results And 2017 Outlook

FOSTER CITY, Calif., March 6, 2017 /PRNewswire/ — SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the fourth quarter and year ended December 31, 2016.

Revenues: In the fourth quarter of 2016, SciClone reported revenues of $44.1 million, compared to